top of page

Ethical Corporate Management

Implementation of Ethical Business Practices

Jia Jie Biomedical Co., Ltd. (the “Company”) has established a Sustainability Development Committee under the Board of Directors, with a Sustainability Task Force operating under its supervision. The committee is responsible for advancing the Group’s corporate governance initiatives, including integrity management, anti-corruption, anti-bribery, and regulatory compliance. It reports its implementation progress to the Board of Directors on an annual basis, with the most recent report delivered on November 11, 2025. The company’s Integrity Management Policy and Code of Conduct are formulated by the Administration Department. Any formulation, amendment, or abolishment of the policy and code must be approved by the Board of Directors. The Board exercises the duty of care of a good steward by overseeing the company’s efforts to prevent unethical behavior and to ensure the effective enforcement of the integrity management policy across all operations.

The implementation status of integrity management for 2025 is presented in the table below:

Supplier Commitment

As of now, all twelve key suppliers have signed and returned the Supplier Commitment Letter, achieving a 100% completion rate. The company will continue to expand this requirement, gradually ensuring that all suppliers sign and adhere to the commitment to ethical, environmental, and social responsibility standards.

Education and Training

During the year, all employees completed integrity education and training programs, with a total of 62 participants and an accumulated 31 training hours.

Commitment

The company achieved a 100% signing rate for the Employee Code of Conduct and Confidentiality Agreement among all new hires upon onboarding.

Awareness Promotion

The company promotes employees’ awareness of integrity and confidentiality responsibilities through the display of posters and related internal communications.

Intellectual Property (IP) Management Plan


To establish standardized procedures for intellectual property management, patent and trademark applications, and related operations, Jia Jie Biomedical Co., Ltd. (the “Company”) aims to promote sustainable business practices, encourage employee innovation, and create high-quality R&D outcomes. Through proactive and systematic intellectual property management, the Company seeks to enhance its operational competitiveness.


1. Trade Secret Management 

  1. Establishing a robust information security environment

  2. To enhance employees’ awareness of protecting the company’s confidential information, the company irregularly promotes the importance of trade secret protection and information security. All employees are required to sign a confidentiality agreement upon onboarding to ensure that intellectual property rights are properly safeguarded.

2. Patent Management 

  1. The design and development are carried out by the R&D department, while external patent firms are irregularly commissioned to conduct patent portfolio planning and application. The company’s Administration Department is responsible for the subsequent protection and maintenance of these intellectual property rights.

  2. The company dynamically tracks the status of its patents and performs appropriate actions for non-continuation, defense, and maintenance as needed.

3. Trademark Management 

The company implements systematic registration and inventory management, conducts annual reviews of trademark validity, and applies for renewals as needed to ensure the continued protection of trademark rights.

 Implementation of IP Management 
The company has been progressively implementing and establishing a comprehensive intellectual property (IP) management plan. In recent years, the main actions have been as follows: the company regularly reports IP-related matters to the Board of Directors. The most recent report was presented at the Board meeting on August 5, 2025.

Implementation Status of Intellectual Property Management in 2025

I. Trademark Management 

Jia Jie Biomedical Co., Ltd. carries out a series of management activities throughout the entire lifecycle of its trademarks, including planning, application, usage, monitoring, protection, and renewal. The purpose is to safeguard brand assets, ensure legal rights, and enhance market competitiveness.

Number of Trademarks: 47 registered trademarks to date.

序號(No.)
商標名稱(Trademark Name)
註冊/審定號(Case No.)
註冊公告日期(Registration Issue Date)
專用期限(Expiry Date)
1
加捷公司標章
00701300
16/01/1996
15/12/2025
2
松森思
00839387
16/03/1999
15/02/2029
3
美心強-P
00864577
16/09/1999
15/08/2029
4
加捷
00866214
01/10/1999
15/12/2025
5
加捷公司標章
01008491
16/08/2002
15/12/2025
6
冷取健康
00186853
16/10/2003
15/09/2033
7
加捷
01055646
01/10/2003
15/12/2025
8
加捷
01059991
01/11/2003
30/09/2033
9
老婆大人
01176989
16/10/2005
15/10/2025
10
舒樂淨 Super-Clean
01176990
16/10/2005
15/10/2025
11
舒化通 Super-Break
01176991
16/10/2005
15/10/2025
12
樂威龍
01194632
01/02/2006
31/01/2026
13
香穗
01897488
16/02/2018
15/02/2028
14
怡悅康
01569746
16/03/2013
15/03/2033
15
神守
01629517
01/03/2014
28/02/2034
16
神守高鈣-P
01639393
01/05/2014
30/04/2034
17
甲魚推手
01719480
01/08/2015
31/07/2025
18
美新強
01746484
01/01/2016
31/12/2025
19
走方
01748270
01/01/2016
31/12/2025
20
美新強
01759278
16/03/2016
15/03/2026
21
倍麗膚Believe 及圖
02040836
16/02/2020
15/02/2030
22
加孅
02064798
16/06/2020
15/06/2030
23
加孅設計字
02064799
16/06/2020
15/06/2030
24
加康健
02018880
01/11/2019
31/10/2029
25
加倍適
02018881
01/11/2019
31/10/2029
26
甲魚晶亮
02018914
01/11/2019
31/10/2029
27
顧菁亮
02018916
01/11/2019
31/10/2029
28
甲魚晶亮
02020032
01/11/2019
31/10/2029
29
加捷生醫股份有限公司標章
02055105
16/04/2020
15/04/2030
30
BIOJJ
02055106
16/04/2020
15/04/2030
31
勁能量-P
01995322
01/07/2019
30/06/2029
32
勁能量-F
01995323
01/07/2019
30/06/2029
33
加沛S
01995326
01/07/2019
30/06/2029
34
捷沛S
01995327
01/07/2019
30/06/2029
35
活立倍
01995328
01/07/2019
30/06/2029
36
悅有勁
01985914
16/05/2019
15/05/2029
37
日行萬步及圖
01865663
01/09/2017
31/08/2027
38
嘉纖
01538464
01/10/2012
30/09/2032
39
加捷
01015091
16/10/2002
15/09/2032
40
加顧
02264469
01/12/2022
30/11/2032
41
加顧
02264679
01/12/2022
30/11/2032
42
加顧
02265174
01/12/2022
30/11/2032
43
加顧
02266080
01/12/2022
30/11/2032
44
加顧
02266400
01/12/2022
30/11/2032
45
甲魚全沛
02275079
16/01/2023
15/01/2033
46
加捷生醫 加紛生活館 JIA JIE BIOMEDICAL 及圖
02314570
16/08/2023
15/08/2033
47
商標名稱:加捷 甲魚精 P 及圖
02350580
16/01/2024
15/01/2034

II. Patent Management

The Company implements planned, strategic, and legal management of patent rights acquired through technological innovation or original inventions. This encompasses the entire lifecycle, including application, protection, utilization, monitoring, and enforcement (rights defense). Our objective is to safeguard technological assets, support business strategies, and enhance corporate competitiveness.

【Number of Patents: 5 patents currently granted】

序號(No.)
專利名稱(Trademark Name)
證書號(Case No.)
公告日(Registration Issue Date)
專利權止日(Expiry Date)
1
軟膠囊結構
M643382
01/07/2023
05/03/2033
2
複合乳酸菌組成物及其用於 製備抑制抗藥性腸桿菌之口 服組成物的用途
I810805
01/08/2023
27/01/2042
3
乳酸菌組成物及其用於製備 抑制抗藥性腸桿菌之口服組 成物的用途
I819483
21/10/2023
27/01/2042
4
合益素組成物及其用於製備 抑制抗藥性腸桿菌之口服組 成物的用途
I819484
21/10/2023
27/01/2042
5
乳酸菌組成物及其用於抑制 抗藥性腸桿菌之乳酸菌組成 物的
7450968
21/10/2022
21/10/2042
  • Facebook
  • YouTube

3F, No. 61, Jiuru 1st Road, Sanmin District, Kaohsiung City, Taiwan

3F., No.61, Jiuru 1st Rd., Sanmin Dist., Kaohsiung City 807, Taiwan

COPYRIGHT © 2025 - JiaJie Biomedical | ALL RIGHTS RESERVED

bottom of page